184 related articles for article (PubMed ID: 37880504)
1. Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab.
Pangua C; Espuelas S; Martínez-Ohárriz MC; Vizmanos JL; Irache JM
Drug Deliv Transl Res; 2024 May; 14(5):1189-1205. PubMed ID: 37880504
[TBL] [Abstract][Full Text] [Related]
2.
Martínez-López AL; González-Navarro CJ; Aranaz P; Vizmanos JL; Irache JM
Acta Pharm Sin B; 2021 Apr; 11(4):989-1002. PubMed ID: 33996411
[TBL] [Abstract][Full Text] [Related]
3. In vivo efficacy of bevacizumab-loaded albumin nanoparticles in the treatment of colorectal cancer.
Luis de Redín I; Expósito F; Agüeros M; Collantes M; Peñuelas I; Allemandi D; Llabot JM; Calvo A; Irache JM
Drug Deliv Transl Res; 2020 Jun; 10(3):635-645. PubMed ID: 32040774
[TBL] [Abstract][Full Text] [Related]
4. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of PEG-coated zein nanoparticles for oral drug delivery purposes.
Reboredo C; González-Navarro CJ; Martínez-Oharriz C; Martínez-López AL; Irache JM
Int J Pharm; 2021 Mar; 597():120287. PubMed ID: 33524523
[TBL] [Abstract][Full Text] [Related]
6. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
[TBL] [Abstract][Full Text] [Related]
7. Cell-penetrating peptide together with PEG-modified mesostructured silica nanoparticles promotes mucous permeation and oral delivery of therapeutic proteins and peptides.
Tan X; Zhang Y; Wang Q; Ren T; Gou J; Guo W; Yin T; He H; Zhang Y; Tang X
Biomater Sci; 2019 Jun; 7(7):2934-2950. PubMed ID: 31094367
[TBL] [Abstract][Full Text] [Related]
8. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
[TBL] [Abstract][Full Text] [Related]
9. Zein-Based Nanoparticles as Oral Carriers for Insulin Delivery.
Reboredo C; González-Navarro CJ; Martínez-López AL; Martínez-Ohárriz C; Sarmento B; Irache JM
Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056935
[TBL] [Abstract][Full Text] [Related]
10. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration.
Inchaurraga L; Martín-Arbella N; Zabaleta V; Quincoces G; Peñuelas I; Irache JM
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):280-9. PubMed ID: 25541441
[TBL] [Abstract][Full Text] [Related]
11. In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization.
Luis de Redín I; Boiero C; Recalde S; Agüeros M; Allemandi D; Llabot JM; García-Layana A; Irache JM
Exp Eye Res; 2019 Aug; 185():107697. PubMed ID: 31228461
[TBL] [Abstract][Full Text] [Related]
12. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
[TBL] [Abstract][Full Text] [Related]
13. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
[TBL] [Abstract][Full Text] [Related]
14. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
[TBL] [Abstract][Full Text] [Related]
15. Zein-based nanocarriers for the oral delivery of insulin. In vivo evaluation in Caenorhabditis elegans.
Martínez-López AL; González-Navarro CJ; Vizmanos JL; Irache JM
Drug Deliv Transl Res; 2021 Apr; 11(2):647-658. PubMed ID: 33515186
[TBL] [Abstract][Full Text] [Related]
16. Insulin loaded mucus permeating nanoparticles: Addressing the surface characteristics as feature to improve mucus permeation.
Pereira de Sousa I; Moser T; Steiner C; Fichtl B; Bernkop-Schnürch A
Int J Pharm; 2016 Mar; 500(1-2):236-44. PubMed ID: 26802494
[TBL] [Abstract][Full Text] [Related]
17. Nanosized Liposomes Containing Bile Salt: A Vesicular Nanocarrier for Enhancing Oral Bioavailability of BCS Class III Drug.
Arafat M; Kirchhoefer C; Mikov M; Sarfraz M; Löbenberg R
J Pharm Pharm Sci; 2017; 20(0):305-318. PubMed ID: 28885915
[TBL] [Abstract][Full Text] [Related]
18. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin.
Tan X; Yin N; Liu Z; Sun R; Gou J; Yin T; Zhang Y; He H; Tang X
Mol Pharm; 2020 Sep; 17(9):3177-3191. PubMed ID: 32697099
[TBL] [Abstract][Full Text] [Related]
19. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Oral Delivery of Protein Drugs Using Zwitterion-Functionalized Nanoparticles to Overcome both the Diffusion and Absorption Barriers.
Shan W; Zhu X; Tao W; Cui Y; Liu M; Wu L; Li L; Zheng Y; Huang Y
ACS Appl Mater Interfaces; 2016 Sep; 8(38):25444-53. PubMed ID: 27588330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
